-Outlook Indian MPs would soon float a forum to advocate elimination of stigma and discrimination against persons affected by Leprosy. "Next parliament session, we will float a forum to end Leprosy and advocate the rights of persons affected by the disease," Trinamool Congress MP Dinesh Trivedi said at an international symposium on Leprosy and human rights in Asia. Also supporting the cause were Minister of State for Human Resource Development and Lok Sabha...

-The Times of India Over-the-counter sale of around 92 antibiotic and anti-tuberculosis drugs in India will be restricted soon. Drug Controller General of India G N Singh has written to the Union health minister to notify a new schedule, H1, in the Drugs and Cosmetics Rules. Once notified, following clearance from the law ministry, these drugs cannot be sold without prescription. The drugs will also have to carry a prominent label in red...

Autistic people stand to benefit in terms of schooling, jobs and welfare projects if a new disability act that is being drafted is enacted into law. The Persons with Disabilities Act, 1995, does not include autism but the government plans to cover the condition in the revised act, accepting a longstanding demand from social activists. Autism is now covered under the National Trust for the Welfare of Persons with Autism, Cerebral Palsy,...

WHO panel proposed treaty requires all governments to share cost   India supports a proposed legally binding global instrument that requires all governments to share the cost of research and development (R&D). The treaty, recommended by a World Health Organisation panel, will boost access to countries least able to pay for medical innovations but need it most. This would also delink profits from medical discoveries. The “Consultative Expert Working Group on Research and...

There has been a six-fold increase in the number of antibiotics being popped by Indians. This includes the retail sale of Carbapenems -- powerful class IV antibiotics, typically used as a "last resort" to treat serious infections caused by multi-drug resistant, gram-negative pathogens. Research by the Centre for Disease Dynamics, Economics and Policy, Washington DC, has found that retail sale of carbapenems increased six times -- from 0.21 units per million...